 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 December 1994 | Volume 121 Issue 11 | Pages 847-854
Objective: To evaluate the frequency of reactivation of genital herpes infection and to identify predictors for recurrence.
Design: Prospective, observational cohort study.
Setting: Research clinic.
Patients: 457 consecutive patients who did not have acute-phase serum antibodies to herpes simplex virus type 2 (HSV-2) but who did have herpes simplex virus (HSV) isolated from genital lesions.
Results: Eighty-nine percent of patients with HSV-2 had at least one recurrence during follow-up (median, 391 days); the median monthly recurrence rate was 0.34. Thirty-eight percent had at least 6 recurrences during the first year and 20% had more than 10 recurrences. The median monthly recurrence rate was 0.43 for men and 0.33 for women (difference, 0.10 [95% CI, 0.03 to 0.19]; P < 0.01). Twenty-six percent of women and 8% of men had no or 1 recurrence in year 1 of follow-up, whereas 14% of women and 26% of men had more than 10 recurrences. Patients who had severe primary HSV-2 infection (duration,
Conclusions: Almost all persons with initially symptomatic HSV-2 infection have symptomatic recurrences. More than 35% of such patients have frequent recurrences. Recurrence rates are especially high in persons with an extended first episode of infection, regardless of whether they receive antiviral chemotherapy with acyclovir. Men with genital HSV-2 infection have about 20% more recurrences than do women, a factor that may contribute to the higher rate of HSV-2 transmission from men to women than from women to men and to the continuing epidemic of genital herpes in the United States.
Author and Article Information
From the University of Washington, Seattle, Washington.
ARTICLE
Recurrence Rates in Genital Herpes after Symptomatic First-Episode Infection
35 days) had recurrences nearly twice as often (0.66 compared with 0.36 recurrences per month [95% CI, 0.18 to 0.57]) and had a shorter time to first recurrence when compared with those who had shorter first episodes.
Requests for Reprints: Lawrence Corey, MD, University of Washington, Virology Division, Room 9301, 1200 12th Avenue South, Seattle, WA 98144.
Acknowledgments: The authors thank Michael Remington, PA, Carol Winter, RN, Cathy Critchlow, PhD, Stacy Selke, MA, Joan Dragavon, Colleen Olson, Michele Crist, Judy Zeh, PhD, Paul Van Veldheisen, MS, Carolyn Lapinsky, WHCS, Anita Fahnlander, RN, and others whose collaborative efforts over a 14-year period made possible the establishment of our genital herpes database.
Grant Support: In part by NIH grants AI-30731 and AI-30619.
This article has been cited by other articles:
|
|
 |
|
  E. E Freeman, K. K Orroth, R. G White, J. R Glynn, R. Bakker, M.-C. Boily, D. Habbema, A. Buve, and R. Hayes Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics Sex. Transm. Inf., August 1, 2007; 83(suppl_1): i17 - i24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A M Geretti Genital herpes Sex. Transm. Inf., December 1, 2006; 82(suppl_4): iv31 - iv34. [Full Text] [PDF]
|
|
|
|
|
|
J S Smith, M Rosinska, A Trzcinska, J M Pimenta, B Litwinska, and J Siennicka Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of Poland. Sex. Transm. Inf., April 1, 2006; 82(2): 159 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A M Geretti and D W Brown National survey of diagnostic services for genital herpes Sex. Transm. Inf., August 1, 2005; 81(4): 316 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Ramaswamy, C McDonald, M Smith, D Thomas, S Maxwell, M Tenant-Flowers, and A M Geretti Diagnosis of genital herpes by real time PCR in routine clinical practice Sex. Transm. Inf., October 1, 2004; 80(5): 406 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Kimberlin and D. J. Rouse Genital Herpes N. Engl. J. Med., May 6, 2004; 350(19): 1970 - 1977. [Full Text] [PDF]
|
|
|
|
|
|
L. Corey, A. Wald, R. Patel, S. L. Sacks, S. K. Tyring, T. Warren, J. M. Douglas Jr., J. Paavonen, R. A. Morrow, K. R. Beutner, et al. Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes N. Engl. J. Med., January 1, 2004; 350(1): 11 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Solomon, M J Cannon, M Reyes, J M Graber, N T Wetherall, and W C Reeves Epidemiology of recurrent genital herpes simplex virus types 1 and 2 Sex. Transm. Inf., December 1, 2003; 79(6): 456 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Narouz, P S Allan, A H Wade, and S Wagstaffe Genital herpes serotesting: a study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UK Sex. Transm. Inf., February 1, 2003; 79(1): 35 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Koelle and L. Corey Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research Clin. Microbiol. Rev., January 1, 2003; 16(1): 96 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Huff, R. Eberle, J. Capitanio, S. S. Zhou, and P. A. Barry Differential detection of B virus and rhesus cytomegalovirus in rhesus macaques J. Gen. Virol., January 1, 2003; 84(1): 83 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Schacker, M. Conant, C. Thoming, T. Stanczak, Z. Wang, and M. Smith Imiquimod 5-Percent Cream Does Not Alter the Natural History of Recurrent Herpes Genitalis: a Phase II, Randomized, Double-Blind, Placebo-Controlled Study Antimicrob. Agents Chemother., October 1, 2002; 46(10): 3243 - 3248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Scoular Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision Sex. Transm. Inf., June 1, 2002; 78(3): 160 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Ribes, A. Smith, M. Hayes, D. J. Baker, and J. L. Winters Comparative Performance of Herpes Simplex Virus Type 1-Specific Serologic Assays from MRL and Meridian Diagnostics J. Clin. Microbiol., March 1, 2002; 40(3): 1071 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Scoular, G Gillespie, and W F Carman Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic Sex. Transm. Inf., February 1, 2002; 78(1): 21 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Ribes, A. D. Steele, J. P. Seabolt, and D. J. Baker Six-Year Study of the Incidence of Herpes in Genital and Nongenital Cultures in a Central Kentucky Medical Center Patient Population J. Clin. Microbiol., September 1, 2001; 39(9): 3321 - 3325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ohana, M. Lipson, N. Vered, I. Srugo, M. Ahdut, and A. Morag Novel Approach for Specific Detection of Herpes Simplex Virus Type 1 and 2 Antibodies and Immunoglobulin G and M Antibodies Clin. Vaccine Immunol., November 1, 2000; 7(6): 904 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Drake, S. Taylor, D. Brown, and D. Pillay Regular review: Improving the care of patients with genital herpes BMJ, September 9, 2000; 321(7261): 619 - 623. [Full Text]
|
|
|
|
 |
|
 B. D. Goldman Herpes Serology for Dermatologists Arch Dermatol, September 1, 2000; 136(9): 1158 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wald, J. Zeh, S. Selke, T. Warren, A. J. Ryncarz, R. Ashley, J. N. Krieger, and L. Corey Reactivation of Genital Herpes Simplex Virus Type 2 Infection in Asymptomatic Seropositive Persons N. Engl. J. Med., March 23, 2000; 342(12): 844 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Benedetti, J. Zeh, and L. Corey Clinical Reactivation of Genital Herpes Simplex Virus Infection Decreases in Frequency over Time Ann Intern Med, July 6, 1999; 131(1): 14 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Schmid, D. R. Brown, R. Nisenbaum, R. L. Burke, D'A. Alexander, R. Ashley, P. E. Pellett, and W. C. Reeves Limits in Reliability of Glycoprotein G-Based Type-Specific Serologic Assays for Herpes Simplex Virus Types 1 and 2 J. Clin. Microbiol., February 1, 1999; 37(2): 376 - 379. [Abstract] [Full Text]
|
|
|
|
|
|
R. L. Ashley and A. Wald Genital Herpes: Review of the Epidemic and Potential Use of Type-Specific Serology Clin. Microbiol. Rev., January 1, 1999; 12(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wald, J. Zeh, S. Selke, R. L. Ashley, and L. Corey Virologic Characteristics of Subclinical and Symptomatic Genital Herpes Infections N. Engl. J. Med., September 21, 1995; 333(12): 770 - 775. [Abstract] [Full Text] [PDF]
|
|
Article
